Biomarkers for Hepatocellular Carcinoma (HCC): An Update View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2015

AUTHORS

Dave Li , Shinji Satomura

ABSTRACT

The past decades have witnessed increased use of biomarkers in disease management. A biomarker is any characteristic that can be objectively measured and evaluated as an indicator of normal biological process, pathogenic process, or pharmacological response to a therapeutic intervention. The clinical measurements of biomarkers can be carried out in vivo using imaging modalities like ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI), as well as in vitro utilizing serum or plasma or other body fluids as specimens. In contrast to the imaging modalities, a prominent value of serum biomarkers is that they could be biologically relevant and disease-specific to pathophysiologic or pathologic process of disease development. This article provides an update of serum biomarkers for hepatocellular carcinoma (HCC) in risk assessment for early detection through surveillance. More... »

PAGES

179-193

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-94-017-7215-0_12

DOI

http://dx.doi.org/10.1007/978-94-017-7215-0_12

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1045258061

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26530367


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biomarkers, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Hepatocellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Early Detection of Cancer", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glycosylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Assessment", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Wako Life Sciences, Inc., 94043, Mountain View, CA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Wako Life Sciences, Inc., 94043, Mountain View, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Li", 
        "givenName": "Dave", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Wako Life Sciences, Inc., 94043, Mountain View, CA, USA", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Wako Life Sciences, Inc., 94043, Mountain View, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Satomura", 
        "givenName": "Shinji", 
        "id": "sg:person.01010774023.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010774023.01"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2015", 
    "datePublishedReg": "2015-01-01", 
    "description": "The past decades have witnessed increased use of biomarkers in disease management. A biomarker is any characteristic that can be objectively measured and evaluated as an indicator of normal biological process, pathogenic process, or pharmacological response to a therapeutic intervention. The clinical measurements of biomarkers can be carried out in vivo using imaging modalities like ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI), as well as in vitro utilizing serum or plasma or other body fluids as specimens. In contrast to the imaging modalities, a prominent value of serum biomarkers is that they could be biologically relevant and disease-specific to pathophysiologic or pathologic process of disease development. This article provides an update of serum biomarkers for hepatocellular carcinoma (HCC) in risk assessment for early detection through surveillance.", 
    "editor": [
      {
        "familyName": "Scatena", 
        "givenName": "Roberto", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-94-017-7215-0_12", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-94-017-7214-3", 
        "978-94-017-7215-0"
      ], 
      "name": "Advances in Cancer Biomarkers", 
      "type": "Book"
    }, 
    "keywords": [
      "hepatocellular carcinoma", 
      "magnetic resonance imaging", 
      "serum biomarkers", 
      "use of biomarkers", 
      "pharmacological response", 
      "pathologic processes", 
      "therapeutic intervention", 
      "resonance imaging", 
      "pathogenic processes", 
      "clinical measurements", 
      "early detection", 
      "biomarkers", 
      "disease management", 
      "carcinoma", 
      "disease development", 
      "normal biological processes", 
      "ultrasound", 
      "modalities", 
      "body fluids", 
      "risk assessment", 
      "serum", 
      "intervention", 
      "tomography", 
      "vitro", 
      "vivo", 
      "surveillance", 
      "update", 
      "past decade", 
      "imaging", 
      "response", 
      "assessment", 
      "management", 
      "plasma", 
      "specimens", 
      "biological processes", 
      "contrast", 
      "fluid", 
      "use", 
      "indicators", 
      "prominent value", 
      "development", 
      "detection", 
      "decades", 
      "values", 
      "article", 
      "measurements", 
      "process"
    ], 
    "name": "Biomarkers for Hepatocellular Carcinoma (HCC): An Update", 
    "pagination": "179-193", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1045258061"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-94-017-7215-0_12"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26530367"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-94-017-7215-0_12", 
      "https://app.dimensions.ai/details/publication/pub.1045258061"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-05-20T07:48", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/chapter/chapter_411.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-94-017-7215-0_12"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-94-017-7215-0_12'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-94-017-7215-0_12'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-94-017-7215-0_12'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-94-017-7215-0_12'


 

This table displays all metadata directly associated to this object as RDF triples.

141 TRIPLES      23 PREDICATES      80 URIs      74 LITERALS      15 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-94-017-7215-0_12 schema:about N0a37928a097848f59a4550acc0860406
2 N180101fdbad1405193620909dbea187a
3 N9cd208a277544ca885dcf9961a09eb57
4 Nabe63894c1ab4bba80d5e451e12ef1f4
5 Nd42720f97a9f4bda8a971156fc41a61d
6 Nf9d9c85fe6fb4c4e85076316b12cb3b5
7 Nfc48dc3deb774007a79d057a4f21708f
8 anzsrc-for:11
9 schema:author N7729c60bcd9a422189705642c448d2cb
10 schema:datePublished 2015
11 schema:datePublishedReg 2015-01-01
12 schema:description The past decades have witnessed increased use of biomarkers in disease management. A biomarker is any characteristic that can be objectively measured and evaluated as an indicator of normal biological process, pathogenic process, or pharmacological response to a therapeutic intervention. The clinical measurements of biomarkers can be carried out in vivo using imaging modalities like ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI), as well as in vitro utilizing serum or plasma or other body fluids as specimens. In contrast to the imaging modalities, a prominent value of serum biomarkers is that they could be biologically relevant and disease-specific to pathophysiologic or pathologic process of disease development. This article provides an update of serum biomarkers for hepatocellular carcinoma (HCC) in risk assessment for early detection through surveillance.
13 schema:editor Na12977263d9240ca80f47eeffde9cefa
14 schema:genre chapter
15 schema:inLanguage en
16 schema:isAccessibleForFree false
17 schema:isPartOf Nf476820147e948409f735dac60474f7e
18 schema:keywords article
19 assessment
20 biological processes
21 biomarkers
22 body fluids
23 carcinoma
24 clinical measurements
25 contrast
26 decades
27 detection
28 development
29 disease development
30 disease management
31 early detection
32 fluid
33 hepatocellular carcinoma
34 imaging
35 indicators
36 intervention
37 magnetic resonance imaging
38 management
39 measurements
40 modalities
41 normal biological processes
42 past decade
43 pathogenic processes
44 pathologic processes
45 pharmacological response
46 plasma
47 process
48 prominent value
49 resonance imaging
50 response
51 risk assessment
52 serum
53 serum biomarkers
54 specimens
55 surveillance
56 therapeutic intervention
57 tomography
58 ultrasound
59 update
60 use
61 use of biomarkers
62 values
63 vitro
64 vivo
65 schema:name Biomarkers for Hepatocellular Carcinoma (HCC): An Update
66 schema:pagination 179-193
67 schema:productId N0d135a15547447b08c36c59780877ae2
68 N5b25bbaa386647d0b28f440516a52f95
69 N6feba40d44a24e16b74ea21032965d5d
70 schema:publisher N093697d5eba84e9fa08d4c82db5d25d0
71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045258061
72 https://doi.org/10.1007/978-94-017-7215-0_12
73 schema:sdDatePublished 2022-05-20T07:48
74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
75 schema:sdPublisher Na65369f0d28c408093debc619fa63c84
76 schema:url https://doi.org/10.1007/978-94-017-7215-0_12
77 sgo:license sg:explorer/license/
78 sgo:sdDataset chapters
79 rdf:type schema:Chapter
80 N093697d5eba84e9fa08d4c82db5d25d0 schema:name Springer Nature
81 rdf:type schema:Organisation
82 N0a37928a097848f59a4550acc0860406 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Risk Assessment
84 rdf:type schema:DefinedTerm
85 N0d135a15547447b08c36c59780877ae2 schema:name dimensions_id
86 schema:value pub.1045258061
87 rdf:type schema:PropertyValue
88 N180101fdbad1405193620909dbea187a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Humans
90 rdf:type schema:DefinedTerm
91 N2f056faf39f6491b9a4c4a5f7f200500 schema:affiliation grid-institutes:None
92 schema:familyName Li
93 schema:givenName Dave
94 rdf:type schema:Person
95 N5b25bbaa386647d0b28f440516a52f95 schema:name doi
96 schema:value 10.1007/978-94-017-7215-0_12
97 rdf:type schema:PropertyValue
98 N6feba40d44a24e16b74ea21032965d5d schema:name pubmed_id
99 schema:value 26530367
100 rdf:type schema:PropertyValue
101 N7729c60bcd9a422189705642c448d2cb rdf:first N2f056faf39f6491b9a4c4a5f7f200500
102 rdf:rest Nf9645153c13748fda9e898e13dd38a33
103 N8c1396409db94124b3c55c92a229ff79 schema:familyName Scatena
104 schema:givenName Roberto
105 rdf:type schema:Person
106 N9cd208a277544ca885dcf9961a09eb57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Biomarkers, Tumor
108 rdf:type schema:DefinedTerm
109 Na12977263d9240ca80f47eeffde9cefa rdf:first N8c1396409db94124b3c55c92a229ff79
110 rdf:rest rdf:nil
111 Na65369f0d28c408093debc619fa63c84 schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 Nabe63894c1ab4bba80d5e451e12ef1f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Glycosylation
115 rdf:type schema:DefinedTerm
116 Nd42720f97a9f4bda8a971156fc41a61d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Liver Neoplasms
118 rdf:type schema:DefinedTerm
119 Nf476820147e948409f735dac60474f7e schema:isbn 978-94-017-7214-3
120 978-94-017-7215-0
121 schema:name Advances in Cancer Biomarkers
122 rdf:type schema:Book
123 Nf9645153c13748fda9e898e13dd38a33 rdf:first sg:person.01010774023.01
124 rdf:rest rdf:nil
125 Nf9d9c85fe6fb4c4e85076316b12cb3b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Carcinoma, Hepatocellular
127 rdf:type schema:DefinedTerm
128 Nfc48dc3deb774007a79d057a4f21708f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Early Detection of Cancer
130 rdf:type schema:DefinedTerm
131 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
132 schema:name Medical and Health Sciences
133 rdf:type schema:DefinedTerm
134 sg:person.01010774023.01 schema:affiliation grid-institutes:None
135 schema:familyName Satomura
136 schema:givenName Shinji
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01010774023.01
138 rdf:type schema:Person
139 grid-institutes:None schema:alternateName Wako Life Sciences, Inc., 94043, Mountain View, CA, USA
140 schema:name Wako Life Sciences, Inc., 94043, Mountain View, CA, USA
141 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...